PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Mindray Recognized by Frost & Sullivan for its Global Expansion and Acquisition Strategy - Based on its recent analysis of the patient monitoring market, Frost & Sullivan recognises Mindray Medical International Limited (Mindray) with the
Mindray Recognized by Frost & Sullivan for its Global Expansion and Acquisition Strategy

 

NewswireToday - /newswire/ - London, United Kingdom, 2010/05/24 - Based on its recent analysis of the patient monitoring market, Frost & Sullivan recognises Mindray Medical International Limited (Mindray) with the "2010 European Patient Monitoring Excellence in Globalisation Award".

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Mindray, which maintains its global base for product development, engineering and manufacturing in China, employs a vertically integrated operating model that enables the company to benefit from unique cost savings and efficiencies. Mindray recently strategically moved its New Jersey outsourced manufacturing capabilities to China in an effort to leverage low-cost technical expertise, labour and raw materials as well as gain a distinct competitive edge in international markets.

In 2008, Mindray acquired Datascope's patient monitoring business in the United States to become the world's third largest patient monitoring brand. This acquisition expanded Mindray's presence outside China as well as its existing worldwide distributor network through the addition of direct sales networks in the United States, the United Kingdom and France.

"The acquisition has also assisted Mindray in effectively understanding market trends, conditions and the changing needs of customers," says Frost & Sullivan Research Analyst Akanksha Joshi. "Mindray expects the acquisition to serve as a strong platform to support sustainable growth of its international business; Mindray has sold its products in more than 160 countries through 13 overseas offices."

The company has worked to form strong, long-term relationships with its suppliers to widen its global base and gain significant cost savings through volume. Generally, Mindray enters into annual contracts with suppliers, allowing for periodic price negotiations that help to reduce manufacturing costs and maintain strong profit margins.

Although the company actively looks to save costs, product quality is paramount to Mindray. This is evidenced by Mindray's independent quality control system, which is dedicated to quality control for the design, manufacture, assembly and testing of products. Mindray was one of the first companies to obtain Technischer Überwachungsverein (TÜV) International Organisation for Standardisation (ISO) 9001/13485 Certification, the Conformité Européenne (CE) mark, as well as Food and Drug Administration (FDA) approval. Mindray actively pursues the delivery of high quality in all aspects of its product portfolio.

"Mindray has three primary product business segments - patient monitoring and life support products, in-vitro diagnostic products, and medical imaging systems," notes Joshi. "Mindray's patient monitoring division offers over 40 different models that monitor patient vital signs in intensive care units, critical care units, operating rooms, emergency rooms and delivery rooms."

Mindray's product portfolio consists of 20 in-vitro diagnostic products and more than 110 reagents that are used in clinics and hospitals to detect various substances in patient samples such as blood, urine and other bodily fluids. The medical imaging systems segment is composed of more than 15 models that help produce real-time images of blood flow and anatomical movements using computer-managed sound waves.

Mindray's customer base primarily ranges from middle to low-end medical device markets. In China, Mindray has the largest customer support and service team with more than 1,000 sales and service staff that work closely with over 2,000 distributors. This network enables the company to provide domestic training, technical support and warranty as well as maintenance and repair services to both end users and distributors.

"Mindray's broad product line and diverse product offering help the company effectively compete against other international participants," observes Joshi. "Through its continuous efforts to improve manufacturing efficiencies and reduce raw material costs, Mindray has been successful in decreasing overall production costs and thereby, passing the cost savings onto its customers."

Each year, Frost & Sullivan presents this award to companies that have established a strategic global footprint and leveraged their global assets. Award recipients have globally integrated their processes and systems, offered enhanced value to customers, exhibited a wider perspective, and see the world as a global community.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.

About Mindray Medical International Limited
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit mindray.com/.

For investor and media inquiries please contact:

In the U.S:
John Capodanno, D
T: +1-212-850-5705
E: john.capodanno[.]fd.com.

Bryan Armstrong, FD
T: +1-(312) 553-6707
E: bryan.armstrong[.]fd.com.

In China:
Cathy Gao, Mindray Investor Relations
T: +86 755 2658 2518
E: cathy.gao[.]mindray.com.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Mindray Recognized by Frost & Sullivan for its Global Expansion and Acquisition Strategy

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jasmine Malone 
+44 207 915 7869 jasmine.malone[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
Insulin Delivery Devices Market Size to Expand at 7% CAGR through 2020 Says PMR
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)